OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

Trustees’ Annual Report for the period

From: 1 April 2023 To: 31 March 2024

Charity name: The Battle Cancer Program Other name the charity uses: The BCP Charity registration number: 1193909

Objectives and Activities

Charitable purposes (as set out in the governing document)

The preservation and promotion of good health by providing tailored functional fitness programs and peer-to-peer community support for individuals in any part of the world affected by ill-health, in particular but not limited to those who have had cancer treatment, as a path to rebuilding physical and mental strength.

Main activities in relation to these purposes for the public benefit

In 2023/24, the charity delivered free 12-week fitness programmes across gyms in the UK and abroad, supporting people affected by cancer to rebuild physical health, regain confidence, and connect with supportive communities.

Public benefit statement

The trustees confirm that they have had regard to the Charity Commission’s guidance on public benefit when planning activities and setting the charity’s objectives.

Policy on grant making

We have no policy on grant making.

Policy on social investment

We have no policy on social investment.

Contribution made by volunteers

Volunteers play a vital role in promoting the charity at events, supporting programme delivery in gyms, and assisting with fundraising activities. Their contribution continues to reduce costs and increase impact.

Achievements and Performance

During the year, the charity:

Achievements against objectives

We have continued to deliver programmes across more than a dozen locations, supporting well over 100 participants during the year.

Performance of fundraising activities

Fundraising has remained challenging in the wider charity sector, but the charity successfully

raised over £74,000 in donations and legacies. Public fundraising, personal challenges, and partnerships with headline sponsors (Nike, Whoop, Tenzing, Moju) remain crucial income streams.

Investment performance

The charity does not hold investments. Income has been directed towards coach payments, programme delivery, and promotion to ensure impact is maximised.

Financial Review

Financial position

Total income for the year was £73,864.11, mainly from donations and legacies. Expenditure totalled £61,586.21. The year closed with a net surplus of £12,277.90, leaving the charity in a positive financial position.

Reserves policy

Reserves are held to protect against a future drop in fundraising and to provide financial stability in uncertain times.

Reserves held

At year end, reserves stood at £60,785.01. The reduction reflects increased programme and staffing costs in 2023/24 as the charity continued to expand delivery and invest in capacity. Charities aim is to keep the reserves above the equivalent to at least three months of operating expenditure.

Going concern

The trustees have no material concerns about the charity continuing as a going concern. Future fundraising remains the main challenge, but diversification of income and sponsor relationships are helping to mitigate this.

Principal sources of funds

Principal risks

The greatest risks are reductions in fundraising income and rising operational costs. The trustees continue to manage these risks by diversifying income, pursuing corporate partnerships, and closely monitoring expenditure.

Structure, Governance and Management

Governing document

The charity is governed by its constitution.

Constitution

The Battle Cancer Program is a Charitable Incorporated Organisation (CIO).

Trustee appointment

There was no change in trustees during the year. Trustees are appointed under the terms of the constitution.

Induction and training of trustees

No formal induction or training policy is in place, though trustees are supported through regular meetings and guidance on roles and responsibilities.

Organisational structure

The Board of Trustees is supported by staff, programme coaches, and volunteers. Committees meet quarterly to oversee finance and fundraising, staffing and volunteers, and programme review.

Reference and Administrative Details

Charity name: The Battle Cancer Program Other name: The BCP Registered charity number: 1193909 Principal address: Move Forward Gym Unit 1–3 Finnimore Industrial Estate Ottery St Mary EX11 NR

Trustees during the year:

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees:

Signature: ____ Full name: _____ Position: Date: _____

Registration number: 1193909

The Battle Cancer Program

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

Kneeshaws Chartered Accountants Fourth Floor St James House St James's Row Burnley Lancashire BB11 1DR

The Battle Cancer Program

Contents

Company Information 1
Profit and Loss Account and Statement of Retained Earnings 2
Balance Sheet 3
Notes to the Unaudited Financial Statements 4 to 6
Detailed Profit and Loss Account 7 to 8

The Battle Cancer Program

Company Information

Chairman Mr S Britton Registered office 1-3 Finnimore Industrial Estate Ottery St Mary EX11 1NR Accountants Kneeshaws Chartered Accountants Fourth Floor St James House St James's Row Burnley Lancashire BB11 1DR

Page 1

The Battle Cancer Program

Profit and Loss Account and Statement of Retained Earnings for the Year Ended 31 March 2024

Note
Turnover
Cost of sales
Gross profit
Administrative expenses
Operating profit/(loss)
Profit/(loss) before tax
4
Profit/(loss) for the financial year
Retained earnings brought forward
Retained earnings carried forward
2024
£
89,875
(9,872)
80,003
(55,101)
24,902
24,902
24,902
60,979
85,881
2023
£
68,611
(20,303)
48,308
(74,750)
(26,442)
(26,442)
(26,442)
87,421
60,979

The notes on pages 4 to 6 form an integral part of these financial statements. Page 2

The Battle Cancer Program

(Registration number: 1193909) Balance Sheet as at 31 March 2024

Note
Fixed assets
Tangible assets
5
Current assets
Stocks
6
Cash at bank and in hand
Creditors: Amounts falling due within one year
7
Net current assets
Net assets
Capital and reserves
Retained earnings
Shareholders' funds
2024
£
4,432
17,277
73,217
90,494
(9,045)
81,449
85,881
85,881
85,881
2023
£
3,969
16,510
48,778
65,288
(8,278)
57,010
60,979
60,979
60,979

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 17 December 2025 and signed on its behalf by:

......................................... Mr S Britton Chairman

The notes on pages 4 to 6 form an integral part of these financial statements. Page 3

The Battle Cancer Program

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1 General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is: 1-3 Finnimore Industrial Estate Ottery St Mary EX11 1NR

These financial statements were authorised for issue by the Board on 17 December 2025.

2 Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:

The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity;

and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Office equipment

Depreciation method and rate

25% per annum reducing balance basis

Page 4

The Battle Cancer Program

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4 Profit/loss before tax

Arrived at after charging/(crediting)

Depreciation expense 2024
£
1,198
2023
£
833

Page 5

The Battle Cancer Program

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

5 Tangible assets

Cost
At 1 April 2023
Additions
At 31 March 2024
Depreciation
At 1 April 2023
Charge for the year
At 31 March 2024
Net book value
At 31 March 2024
At 31 March 2023
6
Stocks
Stock
7
Creditors
Creditors: amounts falling due within one year
Due within one year
Taxation and social security
Accruals and deferred income
Other creditors
Office
equipment
£
5,028
1,662
Total
£
5,028
1,662
6,690
1,059
1,199
2,258
4,432
3,969
2023
£
16,510
6,690
1,059
1,199
2,258
4,432
3,969
2024
£
17,277
2024
£
2,205
840
6,000
9,045
2023
£
2,277
-
6,001
8,278

Page 6

The Battle Cancer Program

Detailed Profit and Loss Account for the Year Ended 31 March 2024

Turnover (analysed below)
Cost of sales (analysed below)
Gross profit
Gross profit (%)
Administrative expenses
Employment costs (analysed below)
Establishment costs (analysed below)
General administrative expenses (analysed below)
Finance charges (analysed below)
Depreciation costs (analysed below)
Operating profit/(loss)
Profit/(loss) before tax
2024
£
89,875
(9,872)
80,003
89.02%
(39,260)
(2,750)
(11,833)
(60)
(1,198)
(55,101)
24,902
24,902
2023
£
68,611
(20,303)
48,308
70.41%
(38,033)
(2,892)
(32,840)
(152)
(833)
(74,750)
(26,442)
(26,442)

This page does not form part of the statutory financial statements. Page 7

The Battle Cancer Program

Detailed Profit and Loss Account for the Year Ended 31 March 2024

Turnover
Donations and legacies
Cost of sales
Opening raw materials
Direct costs
Closing raw materials
Employment costs
Wages and salaries (excluding directors)
Staff NIC (Employers)
Staff pensions (Defined contribution)
Program coach
Establishment costs
Equipment rental
Rent
General administrative expenses
Computer software and maintenance costs
Printing, postage and stationery
Trade subscriptions
Sundry expenses
Travel and subsistence
Advertising
Accountancy fees
Consultancy fees
Finance charges
Bank charges
Depreciation costs
Depreciation of office equipment (owned)
2024
£
89,875
16,510
10,639
(17,277)
9,872
30,595
2,471
622
5,572
39,260
-
2,750
2,750
70
290
273
515
2,682
4,834
840
2,329
11,833
60
1,198
2023
£
68,611
2,237
34,576
(16,510)
20,303
26,858
2,269
348
8,558
38,033
1,392
1,500
2,892
56
463
249
418
8,360
4,315
840
18,139
32,840
152
833

This page does not form part of the statutory financial statements. Page 8

CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Independent Examiner's Report Report to the tru$teesl members of The Battle Cancer Program On accounts for the year ended 3181 March 2024 Charity no (if any) 1193909 Sot out on pages 1 to8 I report to the trustees on my examination of the accounts of the above charity ('Ihe Trust") for the year ended 3110312024. Responsibilities and As the charity Iruslees of the Trust, you are responsible for the preparation basis of report of the accounts in accordance with the requirements of the Charities Act 2011 {"the Act"). I report in respect of my examination of the Trust's accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Direcllons given by the Charity Commission under section 145(5)Ib) of the Act. I have completed my examination. I confirm that no material matters have come to my attention (other than that disclosed below ') in connection with the examination which gives me cause lo believe that in, any material respect.. accounting records wer8 not kept in accordance wlth section 130 of the Act or the accounts do not accord with the accounting records Independent examiner's statement I have no concerns and have come across no other mattors in connection with the examination lo which attention should be drawn in order to enable a proper understanding of the accounts lo be reached. Please delete fhe words in the brackets if they do nol apply. Signed: Date: Andrew James Davies Relevant professional qualificationls) or body {If any): BFP FCA (ICAEW) Address: Fourth Floor Sl James House St James's Row Bumley BB11 1DR IER October 2018

Section B Disclosure Only complete if the examiner needs to highlight mallers of concern {see CC32, Independent examination of charity accounts.. dir8Ctions and guidance for examiners). Give here brief details of any items that the examiner wishes to disclose. IER October 2018